<DOC>
	<DOCNO>NCT01905033</DOCNO>
	<brief_summary>Background : Sepsis major cause in-hospital morbidity mortality . Current tool available clinician initiate therapy patient sepsis mainly comprise symptom classification system culture technique , provide aspecific slow information . Objective : The ultimate goal program assist physician bedside tailor treatment individual patient suffer sepsis generate rapid molecular information causative pathogen host response . Deliverables : Rapid test ( `` sample-in-result-out '' ) use health care personnel close bedside provide rapid information ( within two hour ) presence absence sepsis , causative pathogen risk individual patient sepsis complication death . Design : The program organize four Work Packages ( WPs ) along clinical , discovery technology platform . In WP1 two university hospital enroll 7500 patient admit Intensive Care Unit first 3 year project ; 25 % - 40 % patient develop sepsis . In WP2 ( Pathogen Detection ) , blood obtain patient use develop rapid , fully automate DNA-based bedside test identify microorganism also provide information resistance antibiotic . In WP3 ( Host Response ) , RNA blood cell analyze find novel biomarkers develop rapid easy perform test provide information risk profile patient . In addition , plasma level select protein biomarkers measure comparison value identify leukocyte molecular signature . WP4 responsible ICT management project . The Clinical Platform ( cover WP1 WP4 ) deliver patient data biological sample discovery technology platform . The Discovery Platform ( cover WP2 WP3 ) use patient data biological sample develop test detection infectious agent cause sepsis stratification patient accord risk sepsis complication , include death . The result generate within discovery platform deliver technology platform . The Technology Platform ( part WP2 WP3 ) specific aim develop rapid assay run fully automate ( micro ) fluidics platform easy operate use decentralize setting ( close ) ICU . The developed assay make use knowledge generate discovery platform .</brief_summary>
	<brief_title>Molecular Diagnosis Risk Stratification Sepsis</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<criteria>All patient &gt; 18 year Intensive Care Units AMC Amsterdam UMC Utrecht . Elective cardiac surgery patient uncomplicated stay .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Sepsis</keyword>
	<keyword>Pneumonia</keyword>
	<keyword>Peritonitis</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Transcriptomics</keyword>
	<keyword>Pathogen detection</keyword>
</DOC>